
TTD - Therapeutic Targets Database Full Data Download File
Title - TTD targets information in raw format
Version 7.1.01 (2019.07.14)
Provided by IDRB   Lab of Innovative Drug Reasearch and Bioinformatics
                   College of Pharmaceutical Sciences
                   Zhejiang University
                   https://idrblab.org/
Provided by BIDD   BioInformatic and Drug Design Group
                   Department of Pharmacy
                   National Unviersity of Singapore
                   http://bidd.nus.edu.sg/
Any question about data provided here, please contact with:
Dr. Wang (lfwyx@zju.edu.cn) and Dr. Li (lifengcheng@zju.edu.cn)

--------------------------------------------------------------------------------------------------------
Abbreviations:
TARGETID	TTD Target ID
FORMERID	TTD Former Target ID
UNIPROID	Uniprot ID
TARGNAME	Target Name
GENENAME	Target Gene Name
TARGTYPE	Target Type
SYNONYMS	Synonyms
FUNCTION	Function
PDBSTRUC	PDB Structure
BIOCLASS	BioChemical Class
ECNUMBER	EC Number
SEQUENCE	Sequence
DRUGINFO	TTD Drug ID	Drug Name	Highest Clinical Status
KEGGPATH	KEGG Pathway
WIKIPATH	WiKipathway
WHIZPATH	PathWhiz Pathway
REACPATH	Reactome Pathway
NET_PATH	NetPathway
INTEPATH	Pathway Interact
PANTPATH	PANTHER Pathway
BIOCPATH	BioCyc
--------------------------------------------------------------------------------------------------------

T47101	TARGETID	T47101
T47101	FORMERID	TTDC00024
T47101	UNIPROID	FGFR1_HUMAN
T47101	TARGNAME	Fibroblast growth factor receptor 1 (FGFR1)
T47101	GENENAME	FGFR1
T47101	TARGTYPE	Successful target
T47101	SYNONYMS	c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR
T47101	FUNCTION	Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration.
T47101	PDBSTRUC	6MZW; 6MZQ; 6C1O; 6C1C; 6C1B
T47101	BIOCLASS	Kinase
T47101	ECNUMBER	EC 2.7.10.1
T47101	SEQUENCE	MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWLRDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETDNTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMVGSVIVYKMKSGTKKSDFHSQMAVHKLAKSIPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMPLDQYSPSFPDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPAQLANGGLKRR
T47101	DRUGINFO	D09HNV	Intedanib	Approved
T47101	DRUGINFO	D01PZD	Romiplostim	Approved
T47101	KEGGPATH	hsa04010:MAPK signaling pathway
T47101	KEGGPATH	hsa04014:Ras signaling pathway
T47101	KEGGPATH	hsa04015:Rap1 signaling pathway
T47101	KEGGPATH	hsa04151:PI3K-Akt signaling pathway
T47101	KEGGPATH	hsa04520:Adherens junction
T47101	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells
T47101	KEGGPATH	hsa04810:Regulation of actin cytoskeleton
T47101	KEGGPATH	hsa05200:Pathways in cancer
T47101	KEGGPATH	hsa05205:Proteoglycans in cancer
T47101	KEGGPATH	hsa05215:Prostate cancer
T47101	KEGGPATH	hsa05218:Melanoma
T47101	KEGGPATH	hsa05230:Central carbon metabolism in cancer
T47101	WIKIPATH	WP1911:Signaling by FGFR
T47101	WIKIPATH	WP2064:Neural Crest Differentiation
T47101	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma
T47101	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway
T47101	WIKIPATH	WP2804:Hair Follicle Development: Induction (Part 1 of 3)
T47101	WIKIPATH	WP2857:Mesodermal Commitment Pathway
T47101	WIKIPATH	WP382:MAPK Signaling Pathway
T47101	WIKIPATH	WP474:Endochondral Ossification
T47101	WIKIPATH	WP51:Regulation of Actin Cytoskeleton
T47101	NET_PATH	NetPath_11:TCR Signaling Pathway
T47101	INTEPATH	fgf_pathway:FGF signaling pathway
T47101	INTEPATH	glypican_1pathway:Glypican 1 network
T47101	INTEPATH	ncadherinpathway:N-cadherin signaling events
T47101	INTEPATH	syndecan_4_pathway:Syndecan-4-mediated signaling events
T47101	PANTPATH	P00005:Angiogenesis
T47101	PANTPATH	P00021:FGF signaling pathway

T59328	TARGETID	T59328
T59328	FORMERID	TTDS00355
T59328	UNIPROID	EGFR_HUMAN
T59328	TARGNAME	Epidermal growth factor receptor (EGFR)
T59328	GENENAME	EGFR
T59328	TARGTYPE	Successful target
T59328	SYNONYMS	Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB
T59328	FUNCTION	Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Plays a role in enhancing learning and memory performance (By similarity).
T59328	PDBSTRUC	6D8E; 6B3S; 6ARU; 5ZWJ; 5YU9
T59328	BIOCLASS	Kinase
T59328	ECNUMBER	EC 2.7.10.1
T59328	SEQUENCE	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA
T59328	DRUGINFO	D05UFG	BIBW 2992	Approved
T59328	DRUGINFO	D0N5OV	Cetuximab	Approved
T59328	DRUGINFO	D06XXH	Dacomitinib	Approved
T59328	DRUGINFO	D08TPS	Epidermal growth factor	Approved
T59328	DRUGINFO	D07POC	Erlotinib	Approved
T59328	DRUGINFO	D09XZB	Gefitinib	Approved
T59328	DRUGINFO	D05GGP	HEGF	Approved
T59328	DRUGINFO	D08CDI	Lapatinib	Approved
T59328	DRUGINFO	D03WPP	Necitumumab	Approved
T59328	DRUGINFO	D0U1ZV	NERATINIB MALEATE	Approved
T59328	DRUGINFO	D07YDE	Nitroglycerin	Approved
T59328	DRUGINFO	D0HU9H	Panitumumab	Approved
T59328	DRUGINFO	D03MNN	SKI-758	Approved
T59328	DRUGINFO	D0W5HK	Sorafenib	Approved
T59328	DRUGINFO	D0F0ZE	Tyverb/Tykerb	Approved
T59328	DRUGINFO	D0G6QF	Vandetanib	Approved
T59328	DRUGINFO	D06WRJ	Icotinib hydrochloride	Registered
T59328	DRUGINFO	D0RT2C	AZD9291	Phase 3
T59328	DRUGINFO	D09BKY	Bevacizumab + Erlotinib	Phase 3
T59328	DRUGINFO	D0M4AV	CO-1686	Phase 3
T59328	DRUGINFO	D0FJ1W	DE-766	Phase 3
T59328	DRUGINFO	D0K7FY	EGF816	Phase 3
T59328	DRUGINFO	D0Q9CY	HKI-272	Phase 3
T59328	DRUGINFO	D05FRP	Rindopepimut	Phase 3
T59328	DRUGINFO	D0R4PW	Zalutumumab	Phase 3
T59328	DRUGINFO	D0F3KC	Indium-111	Phase 2/3
T59328	DRUGINFO	D00NYJ	Varlitinib	Phase 2/3
T59328	DRUGINFO	D06XIT	ABT-414	Phase 2
T59328	DRUGINFO	D0P9RG	ABX-EGF	Phase 2
T59328	DRUGINFO	D02BYZ	ASP8273	Phase 2
T59328	DRUGINFO	D0U4FF	BMS-599626	Phase 2
T59328	DRUGINFO	D0R6UV	BMS-690514	Phase 2
T59328	DRUGINFO	D0K9MC	CetuGEX	Phase 2
T59328	DRUGINFO	D0YB3W	CI-1033	Phase 2
T59328	DRUGINFO	D0C3LL	HER1-VSSP vaccine	Phase 2
T59328	DRUGINFO	D00YER	HM-78136B	Phase 2
T59328	DRUGINFO	D0BZ7V	Matuzumab	Phase 2
T59328	DRUGINFO	D09BZJ	MEHD-7945A	Phase 2
T59328	DRUGINFO	D03UKJ	Pazopanib + Tyverb/Tykerb	Phase 2
T59328	DRUGINFO	D0S3PO	Pelitinib	Phase 2
T59328	DRUGINFO	D0CR8H	SYM-004	Phase 2
T59328	DRUGINFO	D0T5JS	TT-100	Phase 2
T59328	DRUGINFO	D0P6DJ	VATALANIB	Phase 2
T59328	DRUGINFO	D04DHZ	CART-EGFR	Phase 1/2
T59328	DRUGINFO	D0G1ZU	EGFR CART	Phase 1/2
T59328	DRUGINFO	D0S8BG	EMD 55900	Phase 1/2
T59328	DRUGINFO	D05ETC	SN-32793	Phase 1/2
T59328	DRUGINFO	D0FF2G	Sym013	Phase 1/2
T59328	DRUGINFO	D0B4OK	Sym015	Phase 1/2
T59328	DRUGINFO	D0V4XY	S-222611	Phase 1b
T59328	DRUGINFO	D05LMC	AMG 595	Phase 1
T59328	DRUGINFO	D0T0SE	Anti-EGFR CAR T	Phase 1
T59328	DRUGINFO	D0JW2O	Anti-HER3/EGFR DAF	Phase 1
T59328	DRUGINFO	D0X7BN	AP32788	Phase 1
T59328	DRUGINFO	D04OLK	AST-1306	Phase 1
T59328	DRUGINFO	D00RMC	BIBX-1382	Phase 1
T59328	DRUGINFO	D08JAN	Cipatinib	Phase 1
T59328	DRUGINFO	D0Z4RC	CUDC-101	Phase 1
T59328	DRUGINFO	D0A6CC	Depatuxizumab	Phase 1
T59328	DRUGINFO	D0I7ZH	EGFR806-specific CAR T cell	Phase 1
T59328	DRUGINFO	D0E7RC	HER-2/HER-1 vaccine	Phase 1
T59328	DRUGINFO	D04HSH	IMGN289	Phase 1
T59328	DRUGINFO	D0U3XL	JNJ-26483327	Phase 1
T59328	DRUGINFO	D01IJM	LY3164530	Phase 1
T59328	DRUGINFO	D01NAP	MM-151	Phase 1
T59328	DRUGINFO	D0N3PC	MR1-1	Phase 1
T59328	DRUGINFO	D0JS0W	PF-05230907	Phase 1
T59328	DRUGINFO	D0FN4T	RM-1929	Phase 1
T59328	DRUGINFO	D0V3XO	Rogaratinib	Phase 1
T59328	DRUGINFO	D00KML	SYN004	Phase 1
T59328	DRUGINFO	D0Z2PC	Pyrrolo[2,3-d]pyrimidine derivative 24	Patented
T59328	DRUGINFO	D07GFF	PKI166	Discontinued in Phase 2
T59328	DRUGINFO	D0E2CQ	RG7160	Discontinued in Phase 2
T59328	DRUGINFO	D02RZL	AZD4769	Discontinued in Phase 1
T59328	DRUGINFO	D0Q7HO	PD-153035	Discontinued in Phase 1
T59328	DRUGINFO	D0A9OV	TAK165	Discontinued in Phase 1
T59328	DRUGINFO	D0V2FZ	111In-hEGF	Preclinical
T59328	DRUGINFO	D0TI4U	EGFR/IGFR tandem adnectin	Preclinical
T59328	DRUGINFO	D0Y1YX	AZD-9935	Terminated
T59328	DRUGINFO	D03QTP	CGP-52411	Terminated
T59328	DRUGINFO	D0HO1S	CGP-53353	Terminated
T59328	DRUGINFO	D02GFZ	Heparin-EGF-like factor	Terminated
T59328	DRUGINFO	D0Y2AM	(3-Bromo-phenyl)-(5-nitro-quinazolin-4-yl)-amine	Investigative
T59328	DRUGINFO	D02ZRO	(3-Bromo-phenyl)-quinazolin-4-yl-amine	Investigative
T59328	DRUGINFO	D06UEK	(E)-5-(4-Hydroxybenzylidene)-1-phenethylhydantoin	Investigative
T59328	DRUGINFO	D0KN1L	(S)-benzyl 4-chloro-3-oxobutan-2-ylcarbamate	Investigative
T59328	DRUGINFO	D0W6CE	10-hydroxy-18-methoxybetaenone	Investigative
T59328	DRUGINFO	D02RIG	2-(4,5-Dihydroxy-indan-1-ylidene)-malononitrile	Investigative
T59328	DRUGINFO	D07IHD	2-(5,6-Dihydroxy-indan-1-ylidene)-malononitrile	Investigative
T59328	DRUGINFO	D00VZA	2-benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile	Investigative
T59328	DRUGINFO	D01NTW	2-cyano-3-(3,4-dihydroxyphenyl)acrylamide	Investigative
T59328	DRUGINFO	D0O9UR	2-methoxy-4-(2-nitrovinyl)phenol	Investigative
T59328	DRUGINFO	D0C9KC	3-(3-Chloro-phenyl)-5,7-dihydroxy-chromen-4-one	Investigative
T59328	DRUGINFO	D0EK0G	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D06AOY	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D00NYT	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D0C3WY	3,4-diphenyl-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D0B8DE	3-Pyridin-4-yl-quinoline-6,7-diol	Investigative
T59328	DRUGINFO	D0K2YY	4-(2-nitroprop-1-enyl)benzene-1,2-diol	Investigative
T59328	DRUGINFO	D0L3SN	4-(2-nitrovinyl)benzene-1,2-diol	Investigative
T59328	DRUGINFO	D0W1BE	4-(2-nitrovinyl)phenol	Investigative
T59328	DRUGINFO	D03HLH	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline	Investigative
T59328	DRUGINFO	D05QMN	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59328	DRUGINFO	D0J9WO	4-(3-Bromo-phenylamino)-quinazoline-6,7-diol	Investigative
T59328	DRUGINFO	D0G4HR	4-(4-(2-nitrovinyl)phenoxysulfonyl)benzoic acid	Investigative
T59328	DRUGINFO	D0I7RA	4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline	Investigative
T59328	DRUGINFO	D0X4OU	4557W	Investigative
T59328	DRUGINFO	D0W2PQ	4-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	Investigative
T59328	DRUGINFO	D0S9QP	4-biphenyl-2-ylethynyl-6,7-dimethoxy-quinazoline	Investigative
T59328	DRUGINFO	D0EH6L	5,6-Bis-p-tolylamino-isoindole-1,3-dione	Investigative
T59328	DRUGINFO	D03WEN	5-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	Investigative
T59328	DRUGINFO	D03CVQ	6,7-diethoxy-4-(4-phenylbut-1-enyl)quinazoline	Investigative
T59328	DRUGINFO	D04LXG	6,7-diethoxy-4-(5-phenylpent-1-enyl)quinazoline	Investigative
T59328	DRUGINFO	D01WXV	6,7-diethoxy-4-styrylquinazoline	Investigative
T59328	DRUGINFO	D0P2GE	6,7-dimethoxy-4-(2-phenylethynyl)quinazoline	Investigative
T59328	DRUGINFO	D00WZG	6,7-dimethoxy-4-(3-phenoxyprop-1-ynyl)quinazoline	Investigative
T59328	DRUGINFO	D0K2VO	6,7-dimethoxy-4-(4-phenylbut-1-ynyl)quinazoline	Investigative
T59328	DRUGINFO	D0DF3Z	6,7-dimethoxy-N-m-tolylquinazolin-4-amine	Investigative
T59328	DRUGINFO	D0J5SK	6-chloro-N-(3-chlorophenyl)quinazolin-4-amine	Investigative
T59328	DRUGINFO	D02FGG	AFM-21	Investigative
T59328	DRUGINFO	D02KVB	AG 112	Investigative
T59328	DRUGINFO	D0H3UI	AG 9	Investigative
T59328	DRUGINFO	D0Q3GG	AG-213	Investigative
T59328	DRUGINFO	D0NH7M	AG-538	Investigative
T59328	DRUGINFO	D0C5WE	AGT-2000	Investigative
T59328	DRUGINFO	D0T7OS	AL-6802	Investigative
T59328	DRUGINFO	D0R2RV	Anti-EGFR humanized mabs	Investigative
T59328	DRUGINFO	D09RXX	Anti-EGFR mab	Investigative
T59328	DRUGINFO	D0GB7F	ARX-AHD	Investigative
T59328	DRUGINFO	D0G9KD	Benzo[g]quinazolin-4-yl-(3-bromo-phenyl)-amine	Investigative
T59328	DRUGINFO	D01WDI	Benzyl-quinazolin-4-yl-amine	Investigative
T59328	DRUGINFO	D04GCH	Bmab-200	Investigative
T59328	DRUGINFO	D0U6WB	BPIQ-I	Investigative
T59328	DRUGINFO	D00TZD	CL-387785	Investigative
T59328	DRUGINFO	D0ZT9D	Cochliobolic acid	Investigative
T59328	DRUGINFO	D0K3FG	EDP-13	Investigative
T59328	DRUGINFO	D03BJB	EGFR inhibitor	Investigative
T59328	DRUGINFO	D05MEY	Epitinib	Investigative
T59328	DRUGINFO	D0D0GS	FHT-2107	Investigative
T59328	DRUGINFO	D0D0YK	GI-3000	Investigative
T59328	DRUGINFO	D05FFT	HDS-029	Investigative
T59328	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T59328	DRUGINFO	D01SQP	HM-61713B	Investigative
T59328	DRUGINFO	D04HGN	HTS-00213	Investigative
T59328	DRUGINFO	D07CZM	HTS-02876	Investigative
T59328	DRUGINFO	D0EP1G	HTS-05058	Investigative
T59328	DRUGINFO	D03ZIW	ICR 62	Investigative
T59328	DRUGINFO	D09KWS	Imaging-theranostic nanoemulsion agents	Investigative
T59328	DRUGINFO	D0AC7C	IPS-01003	Investigative
T59328	DRUGINFO	D03MTY	LA22-radioimmunoconjugates	Investigative
T59328	DRUGINFO	D0D9TU	LAVENDUSTIN A	Investigative
T59328	DRUGINFO	D0V0JV	mabionHER2	Investigative
T59328	DRUGINFO	D0WD8R	MDP-01	Investigative
T59328	DRUGINFO	D0P0JW	MG-111	Investigative
T59328	DRUGINFO	D08RXW	MT-062	Investigative
T59328	DRUGINFO	D0N8TQ	N-(4-(phenylamino)quinazolin-6-yl)acrylamide	Investigative
T59328	DRUGINFO	D01WYI	N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide	Investigative
T59328	DRUGINFO	D0F6FZ	N-(4-m-Tolylamino-quinazolin-7-yl)-acrylamide	Investigative
T59328	DRUGINFO	D0B4PH	N*4*-(3-Bromo-phenyl)-quinazoline-4,6,7-triamine	Investigative
T59328	DRUGINFO	D0HM5W	N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine	Investigative
T59328	DRUGINFO	D0K7GD	N*4*-(3-Bromo-phenyl)-quinazoline-4,7-diamine	Investigative
T59328	DRUGINFO	D05ARF	N*4*-Benzyl-pyrido[4,3-d]pyrimidine-4,7-diamine	Investigative
T59328	DRUGINFO	D00TJF	N4-(3-chlorophenyl)quinazoline-4,6-diamine	Investigative
T59328	DRUGINFO	D0X4UE	N4-(3-methylphenyl)-4,6-quinazolinediamine	Investigative
T59328	DRUGINFO	D0Y6MD	NRC-2694	Investigative
T59328	DRUGINFO	D0CY9O	ON-128	Investigative
T59328	DRUGINFO	D06QEQ	OSI-75	Investigative
T59328	DRUGINFO	D0P3JW	PD-0166326	Investigative
T59328	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T59328	DRUGINFO	D03ATU	PD-158780	Investigative
T59328	DRUGINFO	D01VFR	PD-168393	Investigative
T59328	DRUGINFO	D02GCE	PD182905	Investigative
T59328	DRUGINFO	D0J2CP	PF 5208766	Investigative
T59328	DRUGINFO	D06BJG	PMID24915291C38	Investigative
T59328	DRUGINFO	D07UYV	PMID8568816C56	Investigative
T59328	DRUGINFO	D03EHM	PP121	Investigative
T59328	DRUGINFO	D0A0JL	RG-50810	Investigative
T59328	DRUGINFO	D0AH2V	RM-6427	Investigative
T59328	DRUGINFO	D09XIL	Ro-4396686	Investigative
T59328	DRUGINFO	D0Y1LD	RX-1792	Investigative
T59328	DRUGINFO	D02BXP	Small-molecule cetuximab binding mimics	Investigative
T59328	DRUGINFO	D0Q8GX	SYM-011	Investigative
T59328	DRUGINFO	D0H3FX	TGF alpha	Investigative
T59328	DRUGINFO	D0J3EA	Theliatinib	Investigative
T59328	DRUGINFO	D0ZH1U	TYRPHOSTIN AG-1478	Investigative
T59328	DRUGINFO	D0E5IP	WHI-P154	Investigative
T59328	DRUGINFO	D0NJ3Q	WZ-3146	Investigative
T59328	KEGGPATH	hsa04010:MAPK signaling pathway
T59328	KEGGPATH	hsa04012:ErbB signaling pathway
T59328	KEGGPATH	hsa04014:Ras signaling pathway
T59328	KEGGPATH	hsa04015:Rap1 signaling pathway
T59328	KEGGPATH	hsa04020:Calcium signaling pathway
T59328	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction
T59328	KEGGPATH	hsa04066:HIF-1 signaling pathway
T59328	KEGGPATH	hsa04068:FoxO signaling pathway
T59328	KEGGPATH	hsa04144:Endocytosis
T59328	KEGGPATH	hsa04151:PI3K-Akt signaling pathway
T59328	KEGGPATH	hsa04320:Dorso-ventral axis formation
T59328	KEGGPATH	hsa04510:Focal adhesion
T59328	KEGGPATH	hsa04520:Adherens junction
T59328	KEGGPATH	hsa04540:Gap junction
T59328	KEGGPATH	hsa04810:Regulation of actin cytoskeleton
T59328	KEGGPATH	hsa04912:GnRH signaling pathway
T59328	KEGGPATH	hsa04915:Estrogen signaling pathway
T59328	KEGGPATH	hsa04921:Oxytocin signaling pathway
T59328	KEGGPATH	hsa05120:Epithelial cell signaling in Helicobacter pylori infection
T59328	KEGGPATH	hsa05160:Hepatitis C
T59328	KEGGPATH	hsa05200:Pathways in cancer
T59328	KEGGPATH	hsa05205:Proteoglycans in cancer
T59328	KEGGPATH	hsa05206:MicroRNAs in cancer
T59328	KEGGPATH	hsa05212:Pancreatic cancer
T59328	KEGGPATH	hsa05213:Endometrial cancer
T59328	KEGGPATH	hsa05214:Glioma
T59328	KEGGPATH	hsa05215:Prostate cancer
T59328	KEGGPATH	hsa05218:Melanoma
T59328	KEGGPATH	hsa05219:Bladder cancer
T59328	KEGGPATH	hsa05223:Non-small cell lung cancer
T59328	KEGGPATH	hsa05230:Central carbon metabolism in cancer
T59328	KEGGPATH	hsa05231:Choline metabolism in cancer
T59328	WIKIPATH	WP1843:L1CAM interactions
T59328	WIKIPATH	WP1910:Signaling by EGFR
T59328	WIKIPATH	WP1984:Integrated Breast Cancer Pathway
T59328	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase
T59328	WIKIPATH	WP2004:miR-targeted genes in lymphocytes - TarBase
T59328	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase
T59328	WIKIPATH	WP2100:Arylhydrocarbon receptor (AhR) signaling pathway
T59328	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma
T59328	WIKIPATH	WP2324:AGE/RAGE pathway
T59328	WIKIPATH	WP2363:Gastric cancer network 2
T59328	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway
T59328	WIKIPATH	WP2431:Spinal Cord Injury
T59328	WIKIPATH	WP2586:Aryl Hydrocarbon Receptor
T59328	WIKIPATH	WP2643:Nanoparticle-mediated activation of receptor signaling
T59328	WIKIPATH	WP2653:PIP3 activates AKT signaling
T59328	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK
T59328	WIKIPATH	WP2780:Signaling by ERBB2
T59328	WIKIPATH	WP2781:Signaling by ERBB4
T59328	WIKIPATH	WP2804:Hair Follicle Development: Induction (Part 1 of 3)
T59328	WIKIPATH	WP2828:Bladder Cancer
T59328	WIKIPATH	WP2840:Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
T59328	WIKIPATH	WP2868:TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
T59328	WIKIPATH	WP2870:Extracellular vesicle-mediated signaling in recipient cells
T59328	WIKIPATH	WP2873:Aryl Hydrocarbon Receptor Pathway
T59328	WIKIPATH	WP306:Focal Adhesion
T59328	WIKIPATH	WP382:MAPK Signaling Pathway
T59328	WIKIPATH	WP437:EGF/EGFR Signaling Pathway
T59328	WIKIPATH	WP51:Regulation of Actin Cytoskeleton
T59328	WIKIPATH	WP673:ErbB Signaling Pathway
T59328	REACPATH	R-HSA-1236382:Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
T59328	REACPATH	R-HSA-1250196:SHC1 events in ERBB2 signaling
T59328	REACPATH	R-HSA-1251932:PLCG1 events in ERBB2 signaling
T59328	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling
T59328	REACPATH	R-HSA-179812:GRB2 events in EGFR signaling
T59328	REACPATH	R-HSA-180292:GAB1 signalosome
T59328	REACPATH	R-HSA-180336:SHC1 events in EGFR signaling
T59328	REACPATH	R-HSA-182971:EGFR downregulation
T59328	REACPATH	R-HSA-1963640:GRB2 events in ERBB2 signaling
T59328	REACPATH	R-HSA-1963642:PI3K events in ERBB2 signaling
T59328	REACPATH	R-HSA-2179392:EGFR Transactivation by Gastrin
T59328	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer
T59328	REACPATH	R-HSA-5637810:Constitutive Signaling by EGFRvIII
T59328	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade
T59328	NET_PATH	NetPath_16:IL4 Signaling Pathway
T59328	NET_PATH	NetPath_4:EGFR1 Signaling Pathway
T59328	INTEPATH	a6b1_a6b4_integrin_pathway:a6b1 and a6b4 Integrin signaling
T59328	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly
T59328	INTEPATH	arf6_pathway:Arf6 signaling events
T59328	INTEPATH	ecadherin_keratinocyte_pathway:E-cadherin signaling in keratinocytes
T59328	INTEPATH	ecadherin_stabilization_pathway:Stabilization and expansion of the E-cadherin adherens junction
T59328	INTEPATH	erbb_network_pathway:ErbB receptor signaling network
T59328	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling
T59328	INTEPATH	erbb1_internalization_pathway:Internalization of ErbB1
T59328	INTEPATH	erbb1_receptor_proximal_pathway:EGF receptor (ErbB1) signaling pathway
T59328	INTEPATH	et_egfrpathway:EGFR-dependent Endothelin signaling events
T59328	INTEPATH	lysophospholipid_pathway:LPA receptor mediated events
T59328	INTEPATH	p53downstreampathway:Direct p53 effectors
T59328	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B
T59328	INTEPATH	shp2_pathway:SHP2 signaling
T59328	INTEPATH	syndecan_3_pathway:Syndecan-3-mediated signaling events
T59328	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP
T59328	INTEPATH	telomerasepathway:Regulation of Telomerase
T59328	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling
T59328	INTEPATH	upa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
T59328	PANTPATH	P00012:Cadherin signaling pathway
T59328	PANTPATH	P00018:EGF receptor signaling pathway
